6.2 Preventive Health Screenings & Health Risk Assessments (HRA)
Key Takeaways
- A Health Risk Assessment (HRA) evaluates individual health behaviors, clinical risks, and family history to generate personal action plans and aggregate workforce risk profiles.
- Under HIPAA Privacy Rules and GINA regulations, occupational health programs must strictly protect employee health data, providing employers only with de-identified, aggregated reporting (minimum group size of 20) to prevent discrimination.
- Biometric screenings assess key risk factors including lipid profiles (total cholesterol, HDL, LDL, triglycerides), fasting blood glucose, blood pressure, Body Mass Index (BMI), and waist circumference (abdominal obesity threshold >40 inches in men, >35 inches in women).
- The U.S. Preventive Services Task Force (USPSTF) provides evidence-based screening guidelines for colorectal cancer (ages 45-75), breast cancer (biennial mammography ages 40-74), cervical cancer (cytology/HPV ages 21-65), lung cancer (annual low-dose CT for 20+ pack-year smokers ages 50-80), and prostate cancer (individualized PSA decision ages 55-69).
- The Transtheoretical Model (TTM) guides workplace health coaching across five distinct stages: Precontemplation, Contemplation, Preparation, Action, and Maintenance, tailoring interventions to the individual's stage of readiness.
6.2 Preventive Health Screenings & Health Risk Assessments (HRA)
Quick Summary: Workplace preventive health programs combine self-reported Health Risk Assessments (HRAs) and clinical biometric screenings to identify early disease risks, empower workers with personalized health intelligence, and guide aggregate health promotion strategies. Occupational health nurses must manage these programs under strict legal privacy frameworks—specifically HIPAA and GINA—ensuring that individual employee data remains strictly confidential while providing management with de-identified, population-level health analytics.
Health Risk Assessment (HRA) Design & Privacy Governance
A Health Risk Assessment (HRA) is a structured health survey designed to systematically evaluate an individual's health status, behavioral risk factors, personal medical history, and readiness to change. A comprehensive workplace HRA collects data across three primary domains:
- Behavioral Risk Factors: Nutrition, physical activity, tobacco use, alcohol consumption, sleep hygiene, stress levels, seatbelt use, and sun protection.
- Personal & Family Medical History: History of hypertension, hyperlipidemia, diabetes, cardiovascular disease, stroke, cancer, and mental health disorders.
- Biometric & Physiological Integration: Self-reported or clinically measured height, weight, blood pressure, lipid values, and blood glucose levels.
Clinical & Administrative Utility
For the individual worker, the HRA generates an individualized risk report that highlights elevated health risks and provides actionable guidance. For the occupational health nurse and employer, aggregated HRA data establishes workforce baseline metrics, identifies prevalent chronic disease trends, guides targeted wellness programming (e.g., smoking cessation, weight management, diabetes prevention), and measures long-term program Value on Investment (VOI) and Return on Investment (ROI).
Privacy Protection & Legal Governance (HIPAA & GINA)
Occupational health nurses must enforce rigid privacy barriers to protect employee trust and comply with federal statutes:
- HIPAA Privacy Rule: Individually identifiable Protected Health Information (PHI) collected during voluntary workplace wellness programs or HRAs cannot be shared with employers, human resources, or supervisors for employment decisions (such as hiring, firing, promotions, or performance evaluations).
- Genetic Information Nondiscrimination Act (GINA): Title II of GINA prohibits employers from requesting, requiring, or purchasing genetic information—including family medical history—from employees. Wellness programs offering financial incentives (e.g., premium discounts) CANNOT condition incentives on providing family medical history.
- Aggregate Data Reporting Standards: OHNs may provide employers ONLY with de-identified, aggregate summary reports. To prevent deductive identification of individual participants, aggregate reports must require a minimum group threshold (typically n ≥ 20 participants). If a subgroup has fewer than 20 participants, data must be suppressed or combined with larger cohorts.
Biometric Screenings & Clinical Reference Thresholds
Biometric screenings complement HRAs by providing objective, quantitative physical measurements. Standard workplace biometric protocols assess lipid panels, fasting blood glucose, blood pressure, Body Mass Index (BMI), and waist circumference.
| Biometric Measurement | Normal / Desirable Target | Elevated / Borderline Risk | High Risk / Diagnostic Threshold |
|---|---|---|---|
| Total Cholesterol | < 200 mg/dL | 200–239 mg/dL | ≥ 240 mg/dL |
| HDL Cholesterol | ≥ 40 mg/dL (men)<br/>≥ 50 mg/dL (women) | — | < 40 mg/dL (men)<br/>< 50 mg/dL (women) (Low HDL = high risk) |
| LDL Cholesterol | < 100 mg/dL | 100–159 mg/dL | ≥ 160 mg/dL (≥190 mg/dL = severe hyperlipidemia) |
| Triglycerides | < 150 mg/dL | 150–199 mg/dL | ≥ 200 mg/dL (≥500 mg/dL = pancreatitis risk) |
| Fasting Blood Glucose | < 100 mg/dL | 100–125 mg/dL (Prediabetes) | ≥ 126 mg/dL (Diabetes Mellitus threshold) |
| Body Mass Index (BMI) | 18.5–24.9 kg/m² | 25.0–29.9 kg/m² (Overweight) | ≥ 30.0 kg/m² (Obesity: Class I 30–34.9, Class II 35–39.9, Class III ≥40) |
| Waist Circumference | ≤ 40 in (102 cm) (men)<br/>≤ 35 in (88 cm) (women) | — | > 40 in (102 cm) (men)<br/>> 35 in (88 cm) (women) (Central Obesity) |
Metabolic Syndrome Assessment
Workplace biometric screenings frequently uncover Metabolic Syndrome—a cluster of interconnected metabolic risk factors that increases the risk of cardiovascular disease by 2-fold and Type 2 diabetes by 5-fold. Diagnosis requires meeting at least 3 out of the 5 following criteria:
- Elevated Waist Circumference (>40 in in men, >35 in in women)
- Elevated Triglycerides (≥150 mg/dL, or on drug treatment)
- Reduced HDL Cholesterol (<40 mg/dL in men, <50 mg/dL in women)
- Elevated Blood Pressure (Systolic ≥130 mmHg and/or Diastolic ≥85 mmHg)
- Elevated Fasting Glucose (≥100 mg/dL, or on drug treatment)
USPSTF Evidence-Based Adult Cancer & Disease Screenings
The U.S. Preventive Services Task Force (USPSTF) establishes rigorous, evidence-based recommendations for adult preventive screenings. Occupational health nurses rely on these standards to educate employees and structure corporate screening initiatives:
Core USPSTF Screening Recommendations (2026 Standards)
- Colorectal Cancer Screening (Grade A): All adults aged 45 to 75 years. Recommended screening modalities and intervals: Colonoscopy every 10 years, Annual Fecal Immunochemical Test (FIT), Stool DNA-FIT (sDNA-FIT) every 1 to 3 years, Flexible Sigmoidoscopy every 5 years, or CT Colonography every 5 years.
- Breast Cancer Screening (Grade B): Biennial (every 2 years) screening mammography for women aged 40 to 74 years.
- Cervical Cancer Screening (Grade A): Women aged 21 to 65 years. Women 21–29: Cervical cytology (Pap smear) alone every 3 years. Women 30–65: Cervical cytology every 3 years, high-risk Human Papillomavirus (hrHPV) testing alone every 5 years, or hrHPV co-testing every 5 years.
- Lung Cancer Screening (Grade B): Annual screening with Low-Dose Computed Tomography (LDCT) for adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
- Prostate Cancer Screening (Grade C): Men aged 55 to 69 years. Individualized decision-making regarding Prostate-Specific Antigen (PSA) screening after discussing potential benefits and harms with a provider.
Health Behavior Change: The Transtheoretical Model (TTM) in Workplace Coaching
To translate screening data into sustainable health outcomes, occupational health nurses utilize health behavior change theories. The Transtheoretical Model (TTM)—also known as the Stages of Change—provides a structured framework for workplace health coaching:
The Five Stages of Change (TTM):
1. Precontemplation --> (Not ready: No intent to change within 6 months)
2. Contemplation --> (Getting ready: Intending to change within 6 months; ambivalence)
3. Preparation --> (Ready: Intending to act within 30 days; small initial steps)
4. Action --> (Actively changing: Behavior modified within past 6 months)
5. Maintenance --> (Sustaining: Behavior sustained > 6 months; preventing relapse)
Stage-Matched Nursing Interventions
| TTM Stage | Employee Mindset & Indicators | Targeted OHN Nursing Strategy |
|---|---|---|
| Precontemplation | Unaware, uninformed, or in denial. "I don't need to quit smoking; my grandfather smoked and lived to 90." | Provide non-judgmental education, raise awareness of health risks, encourage self-re-evaluation without pushing immediate action. |
| Contemplation | Aware of benefits but ambivalent about costs/barriers. "I know I need to lose weight, but I don't have time to cook healthy meals." | Explore pros and cons (decisional balance), address perceived barriers, build self-efficacy, encourage expressing feelings about change. |
| Preparation | Has made a decision to act within 30 days. "I bought walking shoes and signed up for the workplace walking challenge starting next week." | Assist in setting SMART goals (Specific, Measurable, Achievable, Relevant, Time-bound), formalize an action plan, connect with wellness resources. |
| Action | Actively engaged in new behavior for < 6 months. High risk of relapse. "I have been smoke-free for 3 weeks using nicotine replacement therapy." | Provide positive reinforcement, identify social support, teach stress coping mechanisms, reframe minor slips as learning opportunities. |
| Maintenance | Sustained target behavior for > 6 months. Behavior becomes habit. "I have maintained a regular exercise schedule for over a year." | Help plan for high-risk relapse triggers (e.g., job stress, travel), consolidate coping strategies, transition employee into peer mentor roles. |
A corporate wellness manager asks the occupational health nurse for a list of individual employee names and their corresponding blood pressure readings and lipid results from a recent biometric screening in order to target wellness incentives. How must the occupational health nurse respond under HIPAA and GINA regulations?
An occupational health nurse evaluates an employee's biometric screening results: fasting blood glucose 112 mg/dL, blood pressure 136/86 mmHg, triglycerides 175 mg/dL, HDL cholesterol 34 mg/dL, and waist circumference 43 inches. What clinical syndrome is represented by these combined metrics?
During a workplace health coaching session, an employee who smokes one pack of cigarettes per day states: 'I bought over-the-counter nicotine patches yesterday, downloaded a quitting app, and marked next Monday on my calendar as my official quit date.' According to the Transtheoretical Model, which stage of change is this employee exhibiting, and what is the nurse's best intervention?